Keck Graduate Institute of Applied Life Sciences
Keck Graduate Institute of Applied Life Sciences Search


Corporate Partnerships
Advisory CouncilCorporate EducationRegulatory Management SeriesProject Management Series for Industry ProfessionalsLife Science Briefing SeriesLife Science Business Development SeriesNext Generation Bioscience Leaders February 1—5, 2010Patents and Patent LawFinance and Management for ScientistsFDA Law and Regulatory AffairsIndustrial Biotech and BiofuelsLife Science Entrepreneur's Business Law PrimerLife Science Project Management Best PracticesMammalian Cell CulturePersonalized Medicine Complimentary PanelQuality Management ProgramRisk Management for Life SciencesScience Boot Camp for Non-ScientistsISB SeminarsBreakfast BriefingsTeam Masters Project - A Corporate OpportunityTechnology TransferVideo and Podcasts



www.kgi.edu

Life Science Business Development Series
March 22-26, 2010
Northern California
LSBD image

 

 

 

 

 

 

 

 

Join other life science professionals to learn all the fundamentals of business development in five days -- or invest in individual days to brush up on a specific skill.

Business development is truly the DNA of the global life science industry, impacting everything from early research through commercial operations.  All sorts of companies - biopharma, medical device, diagnostic, industrial biotech - rely on effective strategies for in- and out-licensing, alliance formation, and contractual collaborations to remain competitive.  Yet, for all its significance, business development is typically not taught in school, but is, instead, a collection of skills learned on the job.  Rather than rely on this slow ad hoc approach, attendees will have the opportunity to gain distilled information in a concentrated period of time from experts at the craft.

KGI's Life Science Business Development Series provides a framework of the key competencies and concepts required for business development success in today's challenging life science marketplace.  Starting with our Strategy class on Monday, March 22, the week proceeds to provide day-long explorations of Patent law/Licensing/Litigation (Tuesday, March 23), Valuation (Wednesday, March 24), Negotiation/Contracts (Thursday, March 25) and Alliance Management (Friday, March 26).

Business issues

Pharmaceutical companies are projected to lose $133 billion in sales as patents expire on blockbuster drugs between 2010 and 2012 (source: EvaluatePharma).  Similar challenges face medical device companies, diagnostic firms, and organizations in the research tools and ag/biofuels/industrial biotech space.  The pressure to deliver business development outcomes will be intense...in all life science sectors.

Who should attend?

  • Individuals requiring more depth in strategy, legal, valuation, negotiation, contracts, or alliance management disciplines
  • Life science professionals who will be adding business development to their job responsibilities

Format

Each one-day class (8:30am to 4:30 pm) features an overview and insight by sector expert(s) plus lively group exercises

Program Fee and Logistics

The program dates are March 22-26, 2010.  Program fee is inclusive of all course materials.  Light breakfast, lunch, and refreshments are provided.

KGI offers participants the opportunity to attend an individual class, attend the entire week, or select several courses that will help achieve his or her career, skill-enhancement, or other goals.  Registrants who complete the entire five day series will receive a certificate of completion.  For one or two classes in a series, the fee is $550/class.  For three or four classes in a series, the fee is $525/class.  For all five classes in a series, it is only $500/class.  Group discounts are available.

Location

Santa Clara University, Santa Clara CA

Click To Register

Individual Class Descriptions
Strategy (Monday, March 22nd)
Patent Law/Licensing/Litigation (Tuesday, March 23rd)
Valuation (Wednesday, March 24th)
Negotiation/Contracts (Thursday, March 25th)
Alliance Management (Friday, March 26th)